A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 59,020 shares of IOVA stock, worth $650,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,020
Previous 58,753 0.45%
Holding current value
$650,990
Previous $870,000 45.63%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$7.78 - $14.19 $2,077 - $3,788
267 Added 0.45%
59,020 $473,000
Q1 2024

Apr 25, 2024

BUY
$7.59 - $17.47 $110,874 - $255,201
14,608 Added 33.09%
58,753 $870,000
Q4 2023

Jan 30, 2024

BUY
$3.3 - $8.89 $17,011 - $45,827
5,155 Added 13.22%
44,145 $358,000
Q3 2023

Oct 25, 2023

BUY
$4.44 - $8.79 $52,525 - $103,985
11,830 Added 43.56%
38,990 $177,000
Q2 2023

Aug 07, 2023

BUY
$5.36 - $9.06 $66,458 - $112,334
12,399 Added 84.0%
27,160 $191,000
Q2 2022

Aug 09, 2022

SELL
$6.38 - $18.33 $22,240 - $63,898
-3,486 Reduced 19.1%
14,761 $163,000
Q1 2022

Apr 21, 2022

SELL
$12.38 - $19.1 $14,373 - $22,175
-1,161 Reduced 5.98%
18,247 $304,000
Q4 2021

Feb 01, 2022

BUY
$16.55 - $27.63 $102,891 - $171,775
6,217 Added 47.13%
19,408 $370,000
Q3 2021

Nov 15, 2021

SELL
$20.35 - $26.63 $122 - $159
-6 Reduced 0.05%
13,191 $325,000
Q2 2021

Jul 30, 2021

BUY
$16.33 - $33.07 $996 - $2,017
61 Added 0.46%
13,197 $343,000
Q1 2021

May 03, 2021

SELL
$28.67 - $52.59 $21,416 - $39,284
-747 Reduced 5.38%
13,136 $416,000
Q4 2020

Jan 28, 2021

BUY
$28.04 - $50.26 $53,948 - $96,700
1,924 Added 16.09%
13,883 $644,000
Q3 2020

Nov 06, 2020

BUY
$27.75 - $36.3 $27,805 - $36,372
1,002 Added 9.14%
11,959 $394,000
Q2 2020

Jul 28, 2020

BUY
$27.21 - $41.0 $45,495 - $68,552
1,672 Added 18.01%
10,957 $301,000
Q1 2020

May 06, 2020

BUY
$19.54 - $38.85 $26,027 - $51,748
1,332 Added 16.75%
9,285 $278,000
Q4 2019

Jan 21, 2020

SELL
$17.95 - $29.41 $24,412 - $39,997
-1,360 Reduced 14.6%
7,953 $220,000
Q2 2019

Jul 30, 2019

SELL
$9.78 - $24.52 $33,300 - $83,490
-3,405 Reduced 26.77%
9,313 $228,000
Q4 2018

Jan 25, 2019

SELL
$7.51 - $11.93 $9,012 - $14,316
-1,200 Reduced 8.62%
12,718 $113,000
Q2 2018

Aug 06, 2018

BUY
$12.45 - $16.95 $66,209 - $90,140
5,318 Added 61.84%
13,918 $178,000
Q1 2018

May 03, 2018

BUY
$8.1 - $19.5 $69,660 - $167,700
8,600 New
8,600 $145,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.